Alert: Regeneron halts distribution of Eylea kits with affected syringes

A recent spike in cases of intraocular inflammation among patients receiving aflibercept (Eylea) appear linked with specific batches of syringes, according to Regeneron Pharmaceuticals.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553